QIAGEN Receives FDA Approval for Companion Diagnostic to Mirati Therapeutics’ KRAZATI in Non-small Cell Lung Cancer therascreen® KRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying [….]
QIAGEN Receives FDA Approval for Companion Diagnostic to Mirati Therapeutics’ KRAZATI in Non-small Cell Lung Cancer
